Homology Medicines has an initial 180-day period through June 26, 2024 to regain compliance with Minimum Bid Price Requirement
Here is the original post:
Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency
Recommendation and review posted by G. Smith
